Stock Report

All about this stock under one free report Last Updated: 06-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

ANG Lifesciences Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 540694

₹34.09

up-down-arrow ₹0.66 (1.97%)

As on 04-Sep-2026IST

Market cap

info icon

₹45 Cr

Revenue (TTM)

info icon

₹84 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

0.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -38.78 -43.10 -17.54 -24.20 -6.65
EBIT -201.52 -820.88 33.60 3.15 -192.46
Net Profit -410.16 -334.31 12.04 -201.83 -211.15
EPS -410.18 -334.31 12.04 -202.67 -210.98
Book Value -- -- -13.32 -7.39 13.92
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-25Mar-24
EBIT-Margin info -1.914.02-9.80-9.341.19
Net Margin info -6.02-0.40-15.83-13.06-6.91
Return on equity info -8.6011.39-23.81-17.70-12.48
Return on Capital info 1.9615.91---4.450.46
Return on Assets info -2.933.34-6.08-5.38-3.97
Debt to Equity (x) info ----0.091.260.91

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
-4.45
0.46
9.59
39.14
Peer Median
--
21.76
21.89
--
17.36
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-23.81

Lower than Peers by 39.16

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-23.81
-17.70
-12.48
-0.31
48.13
Peer Median
15.35
17.93
16.42
--
17.35
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-6.08

Lower than Peers by 16.42

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-6.08
-5.38
-3.97
-0.09
14.06
Peer Median
10.35
12.81
12.32
--
10.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-9.80

Lower than Peers by 27.80

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-9.80
-9.34
1.19
2.45
17.51
Peer Median
18.01
18.93
21.05
--
11.27
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-15.83

Lower than Peers by 30.29

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-15.83
-13.06
-6.91
-0.11
11.35
Peer Median
14.45
14.94
15.51
--
11.45
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

--

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
-6.09
-1.21
4.13
13.04
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

Revenue Growth

-15.60

Lower than Peers by 27.55

Year on year growth in net sales

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-15.60
-36.45
-33.55
-37.94
--
Peer Median
11.95
10.90
13.44
--
11.49
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-24.64

Lower than Peers by 46.24

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-24.64
-600.70
-67.83
-91.32
--
Peer Median
21.60
15.01
23.50
--
-1.10
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

12.04

Lower than Peers by 10.70

Year on year growth in profit after tax

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
12.04
-22.38
-3,768.38
-100.65
--
Peer Median
22.73
14.80
30.12
--
4.90
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

12.04

Lower than Peers by 7.99

Year on year growth in earnings per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
12.04
-22.38
-3,768.23
-100.65
--
Peer Median
20.03
14.27
29.02
--
10.00
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
-16.13
-11.53
2.92
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

0.09

Higher than Peers by 0.08

Total debt / Net worth

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
0.09
1.26
0.91
0.79
0.92
Peer Median
0.00
0.06
0.03
--
0.18
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
0.87
0.66
0.52
0.56
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.97

Lower than Peers by 1.11

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
0.97
1.12
1.20
1.13
1.16
Peer Median
2.08
1.90
2.23
--
1.72
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.66

Lower than Peers by 0.87

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
0.66
0.75
0.87
0.83
0.94
Peer Median
1.54
1.46
1.59
--
1.41
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-0.93

Lower than Peers by 20.30

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-0.93
-0.70
0.06
1.21
6.68
Peer Median
19.38
24.96
45.29
--
24.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

81.27

Higher than Peers by 59.89

Debtors outstanding / Net Sales * 100

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
81.27
71.67
50.15
37.81
28.80
Peer Median
21.38
21.77
20.10
--
23.77
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.38

Lower than Peers by 0.34

Sales / Average Total Assets

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
0.38
0.40
0.57
0.78
1.24
Peer Median
0.72
0.76
0.81
--
1.05
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
274.82
195.39
153.71
105.14
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
200.25
120.23
70.92
38.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
404.81
257.82
168.23
113.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
70.26
57.80
56.40
30.13
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

-3.34

Lower than Peers by 38.27

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-3.34
--
--
--
4.83
Peer Median
34.93
26.81
39.85
--
26.65
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

0.92

Lower than Peers by 4.35

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
0.92
0.46
0.77
1.15
2.90
Peer Median
5.27
4.65
6.11
--
3.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
--
--
--
--
0.43
Peer Median
0.31
0.61
0.37
--
0.04
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-88.98

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
-88.98
351.26
11.33
6.59
4.56
Peer Median
--
27.02
34.57
--
17.31
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

45

Lower than Peers by 21,063

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-25
Mar-24
Mar-23
Mar-22
ANG Lifesciences
45
30
59
99
243
Peer Median
21,107
20,914
25,297
--
474
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...